Literature DB >> 17335364

Effects of full-mouth scaling and root planing in conjunction with systemically administered azithromycin.

Kazuhiro Gomi1, Akihiro Yashima, Takatoshi Nagano, Mikimoto Kanazashi, Nobuko Maeda, Takashi Arai.   

Abstract

BACKGROUND: One-stage full-mouth disinfection (FMD), in which full-mouth scaling and root planing (SRP) is performed with adjunctive use of chlorhexidine, was introduced in 1995. There have been several reports on the effectiveness of this treatment protocol. However, FMD was reported to induce pyrexia frequently. We examined the effects of full-mouth SRP in conjunction with azithromycin administered orally before SRP to control the number of bacteria. The purpose of this study was to compare the effects of full-mouth SRP using azithromycin with conventional SRP.
METHODS: Thirty-four subjects (17 in the test group and 17 in the control group) with severe chronic periodontitis were selected. The subjects of the test group had azithromycin 3 days before full-mouth SRP. Clinical parameters (probing depth [PD], gingival index [GI], bleeding on probing [BOP], and gingival crevicular fluid [GCF]), total number of bacteria, and number of black pigment-producing rods (BPRs) were evaluated at baseline and 5, 13, and 25 weeks after baseline.
RESULTS: All clinical parameters improved in the test group more than in the control group. In the bacteriologic examination, the total number of bacteria did not change during the examination. In the test group, BPRs were not detected until 13 weeks. However, BPRs were detected in the control group by 13 weeks.
CONCLUSION: It was shown that full-mouth SRP using systemically administered azithromycin was a clinically and bacteriologically useful basic periodontal treatment for severe chronic periodontitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335364     DOI: 10.1902/jop.2007.060247

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  18 in total

1.  Disease severity, debridement approach and timing of drug modify outcomes of adjunctive azithromycin in non-surgical management of chronic periodontitis: a multivariate meta-analysis.

Authors:  Nithya Jagannathan; Aneesha Acharya; Ong Yi Farn; Kar Yan Li; Luigi Nibali; George Pelekos
Journal:  BMC Oral Health       Date:  2019-04-27       Impact factor: 2.757

Review 2.  Non-surgical periodontal therapy supplemented with systemically administered azithromycin: a systematic review of RCTs.

Authors:  Sabrina L Buset; Nicola U Zitzmann; Roland Weiger; Clemens Walter
Journal:  Clin Oral Investig       Date:  2015-06-12       Impact factor: 3.573

Review 3.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

4.  Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.

Authors:  Pin-Chuang Lai; Mark R Schibler; John D Walters
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

5.  Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis.

Authors:  H Maezono; Y Noiri; Y Asahi; M Yamaguchi; R Yamamoto; N Izutani; H Azakami; S Ebisu
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

6.  Systemic azithromycin as an adjunct to scaling and root planing in patients with stage III/IV periodontitis: 12-month results of a randomized controlled clinical trial.

Authors:  Katja Povšič; Katarina Čuk; Suzana Milavec; Vanja Erčulj; Katja Seme; Rok Gašperšič
Journal:  Clin Oral Investig       Date:  2021-03-30       Impact factor: 3.573

7.  Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro.

Authors:  C J Doyle; T R Fitzsimmons; C Marchant; A A S S K Dharmapatni; R Hirsch; P M Bartold
Journal:  Clin Oral Investig       Date:  2014-05-08       Impact factor: 3.573

8.  Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis.

Authors:  Jason D Johnson; Ruoqiong Chen; Patricia A Lenton; Guizhen Zhang; James E Hinrichs; Joel D Rudney
Journal:  J Periodontol       Date:  2008-12       Impact factor: 6.993

Review 9.  Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases.

Authors:  Joe W Krayer; Renata S Leite; Keith L Kirkwood
Journal:  Dent Clin North Am       Date:  2010-01

10.  Macrolide antibiotics like azithromycin increase lipopolysaccharide-induced IL-8 production by human gingival fibroblasts.

Authors:  A Kamemoto; T Ara; T Hattori; Y Fujinami; Y Imamura; Pao-Li Wang
Journal:  Eur J Med Res       Date:  2009-07-22       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.